Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in Jordanians

Pharmacogenetics. 1994 Jun;4(3):159-61. doi: 10.1097/00008571-199406000-00007.

Authors

H F Hadidi¹, S Cholerton, S C Monkman, M Armstrong, Y M Irshaid, N M Rawashdeh, A K Daly, J R Idle

Affiliation

¹ Department of Pharmacology, Faculty of Medicine, Jordan University of Science and Technology, Irbid.

PMID: 7920696
DOI: 10.1097/00008571-199406000-00007

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Alleles
Cytochrome P-450 CYP2D6
Cytochrome P-450 Enzyme System / genetics*
Cytochrome P-450 Enzyme System / metabolism
Debrisoquin / metabolism
Gene Frequency
Genotype
Humans
Jordan
Mixed Function Oxygenases / genetics*
Mixed Function Oxygenases / metabolism
Phenotype
Polymorphism, Genetic*

Substances

Cytochrome P-450 Enzyme System
Mixed Function Oxygenases
Cytochrome P-450 CYP2D6
Debrisoquin